Abeona Therapeutics INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersCleveland, OH
SAM.gov UEIDYQWTZCDML71
Abeona Therapeutics is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. The company manufactures ZEVASKYN (prademagene zamikeracel), approved in April 2025, at its cGMP manufacturing facility in Cleveland, Ohio, and is developing PSMA-SIR-T, an engineered T-cell therapy targeting Prostate-Specific Membrane Antigen for solid tumors.
Summarized from the company’s own website
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Abeona Therapeutics INC. | Cleveland | OH | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.